한빛사944건

• • Athira Raveendran(전남대학교)

  • 서진희(전남대학교, Massachusetts General Hospital and Harvard Medical School)

  • 최학수(Massachusetts General Hospital and Harvard Medical School)

  • 조훈성(전남대학교)

  Lysosome-Targeted Bifunctional Therapeutics Induce Autodynamic Cancer Therapy

  • Adv. Sci. Sep 04 2024, | https://doi.org/10.1002/advs.202401424

  • 2024.09
  • 바이오·의료융합

• • 백승민(기초과학연구원, 서울대학교)

  • 김현민(고려대학교 의과대학)

  • 이윤정(서울대학교, 기초과학연구원)

  • 소민(서울대학교, 현텍엔바이오)

  • 현택환(서울대학교)

  • 김치경(고려대학교 구로병원)

  Orally Deliverable Iron-Ceria Nanotablets for Treatment of Inflammatory Bowel Disease

  • Adv. Healthc. Mater. Sep 05 2024, | https://doi.org/10.1002/adhm.202401994

  • 2024.09
  • 바이오·의료융합

• • 정회성(NIDDK / National Institutes of Health)

  Single-Molecule Characterization of Heterogeneous Oligomer Formation during Co-Aggregation of 40- and 42-Residue Amyloid-β

  • J. Am. Chem. Soc. Sep 04 2024, 146 (35) | https://doi.org/10.1021/jacs.4c06372

  • 2024.09
  • 생명과학

• • Hy Dinh Nguyen(아주대학교)

    Interview

  • 이범진(아주대학교)

  Novel pH-Responsive Structural Rearrangement of Myristic Acid-Conjugated Quetiapine Nanosuspension for Enhanced Long-Acting Delivery Performance

  • Adv. Sci. Sep 03 2024, | https://doi.org/10.1002/advs.202405200

  • 2024.09
  • 의약학
• 

  Hy Dinh Nguyen

  아주대학교

  Quetiapine (QTP) is a first-line antipsychotic drug for the treatment of schizophrenia; however, lifelong daily administration of QTP tablets is associated with a low patient acceptance profile. Accordingly, substituting oral dosage forms with long-acting injectables can potentially improve patient compliance and treatment effectiveness.

  • Adv. Sci.
  • 2024.09.11

• • 유민희(안전성평가연구소)

  • 김용범(안전성평가연구소)

  Potential of 6‘?hydroxy justicidin B from Justicia procumbens as a therapeutic agent against coronavirus disease 2019

  • Phytomedicine Aug 31 2024, 134 S0944-7113(24)00671-8 | https://doi.org/10.1016/j.phymed.2024.156014

  • 2024.08
  • 의약학

• • Fakhar Ud Din(한양대학교 약학대학)

  • 김정석(한양대학교 약학대학)

  • 최한곤(한양대학교 약학대학)

  Injectable dual thermoreversible hydrogel for sustained intramuscular drug delivery

  • J. Control. Release Aug 30 2024, 374 S0168-3659(24)00584-4 | https://doi.org/10.1016/j.jconrel.2024.08.034

  • 2024.08

• • 김종승(고려대학교)

  RNA-Activatable Near-Infrared Photosensitizer for Cancer Therapy

  • J. Am. Chem. Soc. Aug 31 2024, | https://doi.org/10.1021/jacs.4c09470

  • 2024.08

• • 나윤영(POSTECH)

  • 김원종(POSTECH)

  Tailored small molecule for inflammation treatment: Dual scavenger targeting nitric oxide and reactive oxygen species

  • J. Control. Release Aug 29 2024, 374 S0168-3659(24)00573-X | https://doi.org/10.1016/j.jconrel.2024.08.026

  • 2024.08
  • 바이오·의료융합

• • 정예희(이화여자대학교 약학대학)

  • 신수민(이화여자대학교)

  • 서원효(이화여자대학교)

  • 이혁진(이화여자대학교 약학대학)

  Engineered lipid nanoparticles enable therapeutic gene silencing of GTSE1 for the treatment of liver fibrosis

  • J. Control. Release Aug 22 2024, 374 S0168-3659(24)00551-0 | https://doi.org/10.1016/j.jconrel.2024.08.012

  • 2024.08
  • 의약학

• • 김나영(경희대학교)

    Interview

  • 안광석(경희대학교, 한의과대학)

  A new 1,2,3-triazole-indirubin hybrid suppresses tumor growth and pulmonary metastasis by mitigating the HGF/c-MET axis in hepatocellular carcinoma

  • J. Adv. Res. Aug 29 2024, S2090-1232(24)00377-1 | https://doi.org/10.1016/j.jare.2024.08.033

  • 2024.08
  • 의약학

• • 장민철(KAIST)

  • 박지호(KAIST)

  Inhalable mRNA Nanoparticle with Enhanced Nebulization Stability and Pulmonary Microenvironment Infiltration

  • ACS Nano Aug 22 2024, | https://doi.org/10.1021/acsnano.4c05653

  • 2024.08
  • 바이오·의료융합

• • 임호영(성균관대학교 의과대학, 삼성서울병원)

  Efficacy and safety of bintrafusp alfa in two phase 1 expansion cohorts with advanced hepatocellular carcinoma

  • Hepatology Aug 13 2024, | https://doi.org/10.1097/HEP.0000000000001054

  • 2024.08
  • 의약학

• • 김선필(기초과학연구원)

    Interview

  • 김예지(안전성평가연구소, UST)

    Interview

  • 이창준(기초과학연구원)

  • 우동호(안전성평가연구소, UST)

  Dopamine-modified hyaluronic acid (DA-HA) as a novel dopamine-mimetics with minimal autoxidation and cytotoxicity

  • Redox Biol. Aug 20 2024, 76 S2213-2317(24)00298-2 | https://doi.org/10.1016/j.redox.2024.103320

  • 2024.08
  • 생명과학

• • 김태민(서울대학교병원, 서울대학교 의과대학)

  Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphoma

  • Ann. Oncol. Aug 13 2024, S0923-7534(24)03759-1 | https://doi.org/10.1016/j.annonc.2024.08.2239

  • 2024.08
  • 의약학

• • 류지연(Harvard Medical School, Brigham and Women’s Hospital)

  • 류일환(국민대학교)

  Brain-targeted intranasal delivery of protein-based gene therapy for treatment of ischemic stroke

  • Theranostics 2024.08.12 ;14(12):4773-4786 | https://www.thno.org/v14p4773

  • 2024.08
  • 바이오·의료융합

• • 이용욱(University of Massachusetts Chan Medical School)

    Interview

  Host?microbe interactions rewire metabolism in a C.?elegans model of leucine breakdown deficiency

  • Nat Metab. 08 August 2024 | https://doi.org/10.1038/s42255-024-01098-5

  • 2024.08
  • 생명과학

• • 배은솔(동아대학교)

  • 김송연(동아대학교)

  • 조완섭(동아대학교)

  The oxidative stress-dependent pulmonary inflammation of inhalable multi-walled carbon nanotube-containing nano-concrete dust and its comparison with

  • J. Hazard. Mater. Jul 15 2024, 476 S0304-3894(24)01793-X | https://doi.org/10.1016/j.jhazmat.2024.135214

  • 2024.07
  • 의약학

• • 안희성(서울아산병원)

  • 이소연(울산대학교 의과대학, 서울아산병원)

  • 김경곤(울산대학교 의과대학, 서울아산병원)

  • 홍수종(울산대학교 의과대학, 서울아산병원)

  Polyhexamethylene guanidine aerosol causes irreversible changes in blood proteins that associated with the severity of lung injury

  • J. Hazard. Mater. Jul 27 2024, 478 S0304-3894(24)01938-1 | https://doi.org/10.1016/j.jhazmat.2024.135359

  • 2024.07
  • 의약학

• • 채영광(Northwestern University Feinberg School of Medicine)

  Phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: adrenocortical carcinoma cohort

  • J. Immunother. Cancer Jul 27 2024, 12 (7) e009074 | https://doi.org/10.1136/jitc-2024-009074

  • 2024.07
  • 의약학